-
2
-
-
0026064751
-
-
B.E. Tomczuk, C.R. Taylor Jr., L.M. Moses, D.B. Sutherland, Y.S. Lo, D.N. Johnson, W.B. Kinnier, and B.F. Kilpatrick J. Med. Chem. 34 1991 2993
-
(1991)
J. Med. Chem.
, vol.34
, pp. 2993
-
-
Tomczuk, B.E.1
Taylor Jr., C.R.2
Moses, L.M.3
Sutherland, D.B.4
Lo, Y.S.5
Johnson, D.N.6
Kinnier, W.B.7
Kilpatrick, B.F.8
-
7
-
-
0032913201
-
-
K.-J. Soderlind, B. Gorodetsky, A.K. Singh, N. Bachur, G.G. Miller, and J.W. Lown Anti-cancer Drug Design 14 1999 19
-
(1999)
Anti-cancer Drug Design
, vol.14
, pp. 19
-
-
Soderlind, K.-J.1
Gorodetsky, B.2
Singh, A.K.3
Bachur, N.4
Miller, G.G.5
Lown, J.W.6
-
8
-
-
0001325629
-
-
As inhibitors of DNA topoisomerases: J.S. Kim, B. Gatto, C. Yu, A. Liu, L.F. Liu, and E.J. LaVoie J. Med. Chem. 39 1996 992
-
(1996)
J. Med. Chem.
, vol.39
, pp. 992
-
-
Kim, J.S.1
Gatto, B.2
Yu, C.3
Liu, A.4
Liu, L.F.5
Lavoie, E.J.6
-
11
-
-
0031463691
-
-
As HIV-reverse transcriptase inhibitors: T. Roth, M.L. Morningstar, P.L. Boyer, S.H. Hughes, R.W. Buckheit Jr., and C.J. Michejda J. Med. Chem. 40 1997 4199
-
(1997)
J. Med. Chem.
, vol.40
, pp. 4199
-
-
Roth, T.1
Morningstar, M.L.2
Boyer, P.L.3
Hughes, S.H.4
Buckheit Jr., R.W.5
Michejda, C.J.6
-
18
-
-
0017872205
-
-
R.R. Tidwell, J.D. Geratz, O. Dann, G. Volz, D. Zeh, and H. Loewe J. Med. Chem. 21 1978 613 623
-
(1978)
J. Med. Chem.
, vol.21
, pp. 613-623
-
-
Tidwell, R.R.1
Geratz, J.D.2
Dann, O.3
Volz, G.4
Zeh, D.5
Loewe, H.6
-
19
-
-
0027253921
-
-
T.A. Fairley, R.R. Tidwell, I. Donkor, N.A. Naiman, K.A. Ohemeng, R.J. Lombardy, J.A. Bentley, and M. Cory J. Med. Chem. 36 1993 1746 1753
-
(1993)
J. Med. Chem.
, vol.36
, pp. 1746-1753
-
-
Fairley, T.A.1
Tidwell, R.R.2
Donkor, I.3
Naiman, N.A.4
Ohemeng, K.A.5
Lombardy, R.J.6
Bentley, J.A.7
Cory, M.8
-
26
-
-
0026726475
-
-
M.P. Singh, T. Joseph, S. Kumar, Y. Bathini, and J.W. Lown Chem. Res. Toxicol. 5 1992 597
-
(1992)
Chem. Res. Toxicol.
, vol.5
, pp. 597
-
-
Singh, M.P.1
Joseph, T.2
Kumar, S.3
Bathini, Y.4
Lown, J.W.5
-
27
-
-
0030300024
-
-
R.S. Harapanhalli, L.W. McLaughlin, R.W. Howell, D.V. Rao, S.J. Adelstein, and A.I. Kassis J. Med. Chem. 39 1996 4804
-
(1996)
J. Med. Chem.
, vol.39
, pp. 4804
-
-
Harapanhalli, R.S.1
McLaughlin, L.W.2
Howell, R.W.3
Rao, D.V.4
Adelstein, S.J.5
Kassis, A.I.6
-
28
-
-
0035899191
-
-
E. Verner, B.A. Katz, J.R. Spencer, D. Allen, J. Hataye, W. Hruzewicz, H.C. Hui, A. Kolesnikov, Y. Li, C. Luong, A. Martelli, K. Radika, R. Rai, M. She, W. Shrader, P.A. Sprengeler, S. Trapp, J. Wang, W.B. Young, and R.L. Mackman J. Med. Chem. 44 2001 2753 2771
-
(2001)
J. Med. Chem.
, vol.44
, pp. 2753-2771
-
-
Verner, E.1
Katz, B.A.2
Spencer, J.R.3
Allen, D.4
Hataye, J.5
Hruzewicz, W.6
Hui, H.C.7
Kolesnikov, A.8
Li, Y.9
Luong, C.10
Martelli, A.11
Radika, K.12
Rai, R.13
She, M.14
Shrader, W.15
Sprengeler, P.A.16
Trapp, S.17
Wang, J.18
Young, W.B.19
MacKman, R.L.20
more..
-
32
-
-
0000997887
-
-
H. Chikashita, S. Nishida, M. Miyazaki, Y. Morita, and K. Itoh Bull. Chem. Soc. Jpn. 60 1987 737
-
(1987)
Bull. Chem. Soc. Jpn.
, vol.60
, pp. 737
-
-
Chikashita, H.1
Nishida, S.2
Miyazaki, M.3
Morita, Y.4
Itoh, K.5
-
37
-
-
0035907479
-
-
M.A. Weidner-Wells, K.A. Ohemeng, V.N. Nguyen, S. Fraga-Spano, M.J. Macielag, H.M. Werblood, B.D. Foleno, G.C. Webb, J.F. Barrett, and D.J. Hlasta Bioorg. Med. Chem. Lett. 11 2001 1545 1548
-
(2001)
Bioorg. Med. Chem. Lett.
, vol.11
, pp. 1545-1548
-
-
Weidner-Wells, M.A.1
Ohemeng, K.A.2
Nguyen, V.N.3
Fraga-Spano, S.4
MacIelag, M.J.5
Werblood, H.M.6
Foleno, B.D.7
Webb, G.C.8
Barrett, J.F.9
Hlasta, D.J.10
-
39
-
-
0029983537
-
-
R.L. Lombardy, F.A. Tanious, K. Ramachandran, R.R. Tidwell, and W.D. Wilson J. Med. Chem. 39 1996 1452 1462
-
(1996)
J. Med. Chem.
, vol.39
, pp. 1452-1462
-
-
Lombardy, R.L.1
Tanious, F.A.2
Ramachandran, K.3
Tidwell, R.R.4
Wilson, W.D.5
-
42
-
-
19544373003
-
-
note
-
General procedure: A solution of 3,4-diaminotoluene (0.25 mmol) and benzaldehyde (0.25 mmol) in 1 mL of solvent or neat was placed in a 50 mL capped tube. The tube was flushed with air, capped, and heated for 4 h at refluxing or at 100°C (see Table 1). The reaction mixture was then cooled to room temperature, and diluted to 10 mL with methanol. The crude mixture was then analyzed by a reverse-phase HPLC using a 0.025 M methanol solution of 3,4-diaminotoluene and a 0.025 M methanol solution of 2-phenyl-5- methylbenzimidazole as the standards
-
-
-
-
43
-
-
19544367841
-
-
note
-
8a)
-
-
-
-
44
-
-
19544387822
-
-
note
-
2/MeOH = 15:1) to afford the desired benzimidazole
-
-
-
-
45
-
-
19544388135
-
-
note
-
In some cases, small amounts (<5%) of bis-Schiff's bases resulting from the condensation of one equivalent of diamines with two equivalents of aldehydes were observed
-
-
-
-
46
-
-
19544391480
-
-
note
-
+)
-
-
-
|